Published in Pain on July 01, 1989
Neuropathic pain: a practical guide for the clinician. CMAJ (2006) 1.79
Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc (2010) 1.63
Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage (2001) 1.03
Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig (2014) 0.94
A preliminary report on stem cell therapy for neuropathic pain in humans. J Pain Res (2014) 0.80
Development of a novel location-based assessment of sensory symptoms in cancer patients: preliminary reliability and validity assessment. J Pain Symptom Manage (2008) 0.79
Symptomatology of peripheral neuropathy in an African language. PLoS One (2013) 0.77
Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms. Eye Contact Lens (2016) 0.76
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia (1993) 4.43
Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care (1999) 3.27
A feasibility study of the use of continuous subcutaneous insulin infusion in a diabetic clinic: patients' choice of treatment. Diabet Med (1984) 2.84
Predicting risk of diabetic ketoacidosis in patients using continuous subcutaneous insulin infusion. Br Med J (Clin Res Ed) (1986) 2.79
Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care (2001) 2.60
The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia (1992) 2.38
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet (1999) 2.37
The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care (1994) 2.36
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia (1993) 2.05
The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med (2001) 1.91
Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care (2001) 1.82
The thermodynamics of protein denaturation. 3. The denaturation of ribonuclease in water and in aqueous urea and aqueous ethanol mixtures. J Am Chem Soc (1967) 1.77
Clinical predictors and radiological reliability in atlantoaxial subluxation in Down's syndrome. Arch Dis Child (1991) 1.68
Insulin dependent diabetes in children under 5: incidence and ascertainment validation for 1992. BMJ (1995) 1.63
Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. Br Med J (Clin Res Ed) (1985) 1.62
Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care (1983) 1.61
A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J (2001) 1.59
The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med (1996) 1.56
The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med (1994) 1.53
Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet (1988) 1.42
The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care (1997) 1.42
Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med (1995) 1.41
Prediction of birthweight by fetal ultrasound biometry. Br J Radiol (1992) 1.41
The relationship of static foot structure to dynamic foot function. J Biomech (1997) 1.40
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol (1995) 1.40
Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care (1991) 1.39
Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab (1996) 1.39
Alberta. Suspected ivermectin toxicity in kittens. Can Vet J (1991) 1.38
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care (1998) 1.37
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis (1998) 1.36
A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care (2001) 1.34
Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia (1989) 1.32
Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract (1991) 1.32
Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc Natl Acad Sci U S A (2004) 1.30
Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care (1983) 1.29
Attention and driving performance in Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci (1998) 1.27
Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia (1982) 1.25
A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet Med (1988) 1.24
Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia (1989) 1.23
Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. Lancet (1987) 1.23
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia (2001) 1.20
Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol (2001) 1.19
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care (2001) 1.16
Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract (1998) 1.16
Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care (1995) 1.16
Parent-infant cosleeping: the appropriate context for the study of infant sleep and implications for sudden infant death syndrome (SIDS) research. J Behav Med (1993) 1.15
Lifestyle behaviours of young adult survivors of childhood cancer. Br J Cancer (2002) 1.15
Life events and low birthweight--analysis by infants preterm and small for gestational age. Br J Obstet Gynaecol (1991) 1.13
The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health. Clin Pharmacol Ther (2011) 1.13
Diabetic thoracic polyradiculopathy presenting as abdominal swelling. Br Med J (Clin Res Ed) (1984) 1.12
Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med (1994) 1.12
Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med (1999) 1.11
Gait abnormalities in diabetic neuropathy. Diabetes Care (1997) 1.10
Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract (1996) 1.10
Do people with diabetes wear their prescribed footwear? Diabet Med (1996) 1.08
Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes (1994) 1.08
Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations. Arterioscler Thromb (1991) 1.07
Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care (1994) 1.06
Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care (1993) 1.06
The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care (1985) 1.06
Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care (1999) 1.06
Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) (1986) 1.06
Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol (2000) 1.05
The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med (1991) 1.05
The natural history of painful diabetic neuropathy--a 4-year study. Postgrad Med J (1983) 1.04
Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care (1994) 1.03
Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J (1994) 1.03
Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing (1991) 1.03
The clinical diagnosis of sensory neuropathy in elderly people. Diabet Med (1993) 1.02
The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia (1999) 1.02
A foot care program for diabetic unilateral lower-limb amputees. Diabetes Care (2001) 1.01
Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J (1986) 1.01
Experimental studies of infant-parent co-sleeping: mutual physiological and behavioral influences and their relevance to SIDS (sudden infant death syndrome). Early Hum Dev (1994) 0.98
A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol (1987) 0.98
Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci (Lond) (2000) 0.98
Continuous activity monitoring in persons at high risk for diabetes-related lower-extremity amputation. J Am Podiatr Med Assoc (2001) 0.97
Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol (1992) 0.97
Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia (1990) 0.96
Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes (1998) 0.95
The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med (1992) 0.95
Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? Diabetologia (1987) 0.95
Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia (1993) 0.94
Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry (1992) 0.94
An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care (1998) 0.93
Use of plaster casts in the management of diabetic neuropathic foot ulcers. Diabetes Care (1986) 0.93
Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae. Proc Natl Acad Sci U S A (1990) 0.93
IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol (1994) 0.92
Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications (1998) 0.92
Herpesvirus colitis: a new cause of diarrhoea in a patient with Hodgkin's disease. Gut (1982) 0.92
DCCT: implications for diabetes care in the UK. Diabet Med (1993) 0.92
Diabetic neuropathies and pain. Clin Endocrinol Metab (1986) 0.91
Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat. J Anat (1999) 0.91
The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol (2001) 0.91
BMJ's embargo should not be broken. BMJ (1996) 0.91
Memory and attention problems in children with chronic fatigue syndrome or myalgic encephalopathy. Arch Dis Child (2008) 0.91
Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus. Diabet Med (2001) 0.91
Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J Clin Pathol (1985) 0.91
Analysis of pre- and post-donation haematological values in plateletpheresis donors. Vox Sang (1993) 0.91